Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1079501.RAQQi2PQrjFhPX62NyLMb6tO_5hhTucOwVZwHmYHYBggs130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1079501.RAQQi2PQrjFhPX62NyLMb6tO_5hhTucOwVZwHmYHYBggs130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1079501.RAQQi2PQrjFhPX62NyLMb6tO_5hhTucOwVZwHmYHYBggs130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1079501.RAQQi2PQrjFhPX62NyLMb6tO_5hhTucOwVZwHmYHYBggs130_provenance.
- NP1079501.RAQQi2PQrjFhPX62NyLMb6tO_5hhTucOwVZwHmYHYBggs130_assertion description "[Mesothelin (MSLN) and cancer antigen125/mucin 16 (CA125/MUC16) are potential biomarkers for pancreatic cancer (PC) that are co-overexpressed at the invading edges of PC tissues, and their expression correlates with poor survival rates.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1079501.RAQQi2PQrjFhPX62NyLMb6tO_5hhTucOwVZwHmYHYBggs130_provenance.
- NP1079501.RAQQi2PQrjFhPX62NyLMb6tO_5hhTucOwVZwHmYHYBggs130_assertion evidence source_evidence_literature NP1079501.RAQQi2PQrjFhPX62NyLMb6tO_5hhTucOwVZwHmYHYBggs130_provenance.
- NP1079501.RAQQi2PQrjFhPX62NyLMb6tO_5hhTucOwVZwHmYHYBggs130_assertion SIO_000772 23694968 NP1079501.RAQQi2PQrjFhPX62NyLMb6tO_5hhTucOwVZwHmYHYBggs130_provenance.
- NP1079501.RAQQi2PQrjFhPX62NyLMb6tO_5hhTucOwVZwHmYHYBggs130_assertion wasDerivedFrom befree-2016 NP1079501.RAQQi2PQrjFhPX62NyLMb6tO_5hhTucOwVZwHmYHYBggs130_provenance.
- NP1079501.RAQQi2PQrjFhPX62NyLMb6tO_5hhTucOwVZwHmYHYBggs130_assertion wasGeneratedBy ECO_0000203 NP1079501.RAQQi2PQrjFhPX62NyLMb6tO_5hhTucOwVZwHmYHYBggs130_provenance.
- befree-2016 importedOn "2016-02-19" NP1079501.RAQQi2PQrjFhPX62NyLMb6tO_5hhTucOwVZwHmYHYBggs130_provenance.